Phase I study of S-1

Japanese Journal of Cancer and Chemotherapy

Volumn 24, Issue 15, 1997, Pages 2253-2264

  Taguchi, T ^a   Inuyama, Y ^a   Kanamaru, R ^a   Hasegawa, K ^a   Akazawa, S ^a   Niitani, H ^a   Furue, H ^a   Kurihara, M ^a   Ota, K ^a   Suga, S ^a   Ariyoshi, Y ^a   Takai, S ^a   Shimoyama, T ^a   Toge, T ^a   Takashima, S ^a   Sugimachi, K ^a   Hara, Y ^a   Fujita, H ^a   Kimura, K ^a   Saito, T ^a   Tsukagoshi, S ^a   Nakao, I ^a   more..

^a OSAKA UNIVERSITY   (Japan)

Author keywords

5 FU; Biochemical modulator; CDHP; Oxo; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE; 5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ANTINEOPLASTIC AGENT; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; OXONATE POTASSIUM; TEGAFUR;

ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DOSE RESPONSE; DRUG FORMULATION; DRUG HALF LIFE; HUMAN; LEUKOPENIA; MALAISE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RASH; SOLID TUMOR; STOMATITIS; TUMOR XENOGRAFT; VOMITING;

ADMINISTRATION, ORAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OXONIC ACID; PYRIDINES; TEGAFUR;

EID: 10744224587     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)